Proceedings of the Meeting on "The use of causal probability in medical radiation protection", Pavia, Italy, 22 October 2016
13 April 2017
Vol. 39 No. 2 (2017)
[The stochastic effects of ionising radiation]
Gli effetti stocastici delle radiazioni ionizzanti
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
22
Views
14
Downloads
Authors
Stochastic effects induced by exposure to ionizing radiation rapresent a relevance radioprotection aspect. Actually most of the information about radiation-induced oncogenic risk arise from the follow-up of the atomic bombs survivors (Life Span Study, LSS); at this information sources have been added over the last decades also data derived from medical, occupational and environmental studies conducted in various parts of the world and their contribution about number of cases and duration of follow-up period is of great relevance.
These sources of information, in fact, provide important data related to very different exposure models compared to the historical of the LSS and closer to those who characterize the employment context in the last decades.
Data from these studies seem to outline the evidence for which at the current occupational exposure levels significant ERR/Gy are observed only for lung cancer and for all haematological neoplasms with the exception of chronic lymphocytic leukemia.
Altmetrics
Downloads
Download data is not yet available.
Citations
1) Berrington de Gonzalez A, Gilbert E, Curtis R, Inskip P, Kleinerman R, Morton L, Rajaraman P, Little MP. Second solid cancers after radiotherapy: a systematic review of the epidemiological studies of the radiation dose-response relationship. Int J Radiat Oncol Biol Phys 2013 June 1; 86(2). doi: 10.1016/j-1jrobp.2012.09.001 2) Boice JD Jr, Engholm G, Kleinerman RA. Radiation dose and second cancer risk in patients treated for cancer of the cervix. Radiat Res, 116: 3-55. 1988. doi: 10.2307/3577477 PMID: 3186929 3) Burtt JJ, Patsy A Thompson PA, Lafrenie RM. Non-targeted effects and radiation-induced carcinogenesis: a review. J Radiol Prot 36 (2016) R23-R35 doi: 10.1088/0952-4746/36/1/R23 4) Cardis E, Vrijheid M, Blettner M. Risk of cancer after low doses of ionising radiation: retrospective cohort study in 15 countries. Brit Med J 2005; 9; 331: 77.
5) Cardis E, Vrijheid M, Blettner M, Gilbert E, Hakama M, Hill C, et al. The 15-Country Collaborative Study of Cancer Risk among Radiation Workers in the Nuclear Industry: estimates of radiation-related cancer risks. Radiat Res 2007; 167(4): 396-416. DOI: https://doi.org/10.1667/RR0554.1
6) Committee to Assess Health Risks from Exposure to Low Levels of Ionizing Radiation, National Research Council. Health Risks from Exposure to Low Levels of lonizing Radiation: BEIR VII - Phase 2. ISBN: 0-309-53040-7, 424 pages, 8 1/2 x 11, (2006).
7) Cook PJ, Ju BG, Telese F, Wang X, Glass CK, Rosenfeld MG. Tyrosine dephosphorylation of H2AX modulates apoptosis and survival decisions. Nature 2009; 458: 591-6. DOI: https://doi.org/10.1038/nature07849
8) Darby SC, Reeves G, Key T. Mortality in a cohort of women given X-ray therapy for metropathia haemorrhagica. Int J Cancer 1994; 56: 793-801. doi: 10.1002/ ijc.2910560606 PMID: 8119768 9) Decreto Legislativo 17 marzo 1995 n° 230 modificato dal D.Lgs. 26 maggio 2000, n. 187, dal D.Lgs. 26 maggio 2000, n. 241 dal D.Lgs. 9 maggio 2001, n. 257 dal D.Lgs. 26 marzo 2001, n. 151 e dalla Legge 1 marzo 2002, n. 39 "Attuazione delle direttive 89/618/Euratom, 90/641/Euratom, 92/3/Euratom e 96/29/Euratom in materia di radiazioni ionizzanti".
10) Dropkin G. Reanalysis of cancer mortality in Japanese A-bomb survivors exposed to low doses of radiation: bootstrap and simulation methods. Environmental Health 2009, 8: 56 doi: 10.1186/1476069X-8-56. DOI: https://doi.org/10.1186/1476-069X-8-56
11) Dropkin G. Low dose radiation and cancer in A-bomb survivors: latency and non-linear dose-response in the 1950-90 mortality cohort. Environmental Health 2007, 6: 1 doi: 10.1186/1476-069X-6-1. DOI: https://doi.org/10.1186/1476-069X-6-1
12) European Agency for Safety and Health at Work - EU-OSHA. Exposure to carcinogens and work-related cancer: A review of assessment methods. European Risk Observatory Report. Luxembourg: Publications Office of the European Union, 2014. ISBN: 978-92-9240-500-7. doi: 10.2802/33336 13) European Commission. Information notices on occupational diseases: a guide to diagnosis. Luxembourg: Office for Official Publications of the European Communities, 2009. ISBN 978-92-7911483-0. doi 10.2767/38249.
14) European Commission. Radiation protection 125. Low dose ionizing radiation and cancer risk. Luxembourg: Office for Official Publications of the European Communities, 2001. ISBN 92-894-1693-9. 15) Fernandez-Capetillo O, Lee A, Nussenzweig M, Nussenzweig A. H2AX: the histone guardian of the genome. DNA Repair 2004; 3: 959-67. DOI: https://doi.org/10.1016/j.dnarep.2004.03.024
16) Filippova EM, Monteleone DC, Trunk JG, Sutherland BM, Quake SR, Sutherland JC. Quantifying Double-Strand Breaks and Clustered Damages in DNA by Single-Molecule Laser Fluorescence Sizing. Biophysical Journal Volume 84 February 2003 1281-1290. 17) Furukawa K. Radiation and smoking effects on lung cancer incidence among atomic-bomb survivors. Radiat Res 174, 72-82 (2010). 18) Gilbert ES, Stovall M, Gospodarowicz M. Lung cancer after treatment for Hodgkin's lymphoma: focus on radiation effects. Radiat Res 2003; 159: 161-73. DOI: https://doi.org/10.1016/S0006-3495(03)74943-1
19) Gilbert ES, Sokolnikov ME, Preston DL, Schonfeld SJ, Schadilov AE, Vasilenko EK, et al. Lung cancer risks from plutonium: an updated analysis of data from the Mayak worker cohort. Radiat Res 2013; 179(3): 332-42. DOI: https://doi.org/10.1667/RR3054.1
20) Hou J, Wang F, Kong P, Yu PKN, Wang H, Han W. Gene profiling characteristics of radioadaptative response in AG01522 normal human fibroblasts PLoS One. 2015 Apr 17; 10(4): e0123316. doi: 10.1371/journal.pone.0123316. DOI: https://doi.org/10.1371/journal.pone.0123316
21) ICRP Publication 103 'The 2007 Recommendations of the International Commission on Radiological Protection' Annals of the ICRP Volume 37/2-4, 2008.
22) Inskip PD, Stovall M, Flannery JT. Lung cancer risk and radiation dose among women treated for breast cancer. J Natl Cancer Inst. 1994; 86: 983-8. DOI: https://doi.org/10.1093/jnci/86.13.983
23) International Agency for Research on Cancer. TARC Monographs on the Evaluation of Carcinogenic Risks to Humans; Vol. 100D. A Review of Human Carcinogens. Part D: Radiation/IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, Lyon, France: WHO, 2012.
24) Kadim MA, Moore SR, Goodwin EH. Interrelationship amongst radiation-induced genomic instability, bystander effects, and the adaptive response. Mutation Research 2004; 568, 21-34. DOI: https://doi.org/10.1016/j.mrfmmm.2004.06.043
25) Krishnan N, Jeong DG, Jung SK, et al. Dephosphorylation of the Cterminal tyrosyl residue of the DNA damage-related histone H2A.X is mediated by the protein phosphatase eyes absent. J Biol Chem 2009; 284: 16066-70. DOI: https://doi.org/10.1074/jbc.C900032200
26) Krestinina L Yu, Davis F, Ostroumova EV, Epifanova SB, Degteva MO, Preston DL, Akleyev AV. Solid cancer incidence and low-doserate radiation exposures in the Techa River cohort: 1956-2002. International Journal of Epidemiology 2007; 36: 1038-1046. doi: 10.1093/ije/dym121. DOI: https://doi.org/10.1093/ije/dym121
27) Li CI. Relationship between radiation exposure and risk of second primary cancers among atomic bomb survivors. Cancer Res 70, 7187-7198 (2010). DOI: https://doi.org/10.1158/0008-5472.CAN-10-0276
28) Little MP, de Vathaire F, Shamsaldin A. Risks of brain tumour following treatment for cancer in childhood: modification by genetic factors, radiotherapy and chemotherapy. Int J Cancer 1998; 78: 269-75. 29) Morgan WF. Is there a common mechanism underlying genomic instability, bystander effects and other nontargeted effects of exposure to ionizing radiation? Oncogene 2003; 22, 7094-7099. DOI: https://doi.org/10.1038/sj.onc.1206992
30) Mothersill, C. Seymour. Radiation-induced bystander effects and adaptive response - the Yin and Yang of of low dose radiobiology? Mutation Research 2004; 568, 121-128. DOI: https://doi.org/10.1016/j.mrfmmm.2004.06.050
31) Muirhead CR, O'Hagan JA, Haylock RG, Phillipson MA, Willcock T, Berridge GL, et al. Mortality and cancer incidence following occupational radiation exposure: third analysis of the National Registry for Radiation. Workers Br J Cancer 2009; 100(1): 206-12. DOI: https://doi.org/10.1038/sj.bjc.6604825
32) Ozasa K. Epidemiological research on radiation-induced cancer in atomic bomb survivors. Journal of Radiation Research 2016; pp. 16 doi: 10.1093/jrr/rrw005 33) Ozasa K, Shimizu Y, Suyama A, Kawsagi F, Soda M, Grant EJ, Sakata R, Sugiyama H, Kodama K. Report 14, 1950-2003: an overview of cancer and noncancer diseases. Studies of the mortality of atomic bomb survivors. Radiat Res 2012; 177: 229-243. DOI: https://doi.org/10.1667/RR2629.1
34) Preston DL, Pierce DA, Shimizu Y. Effect of recent changes in atomic bomb survivor dosimetry on cancer mortality risk estimates. Radiat Res 2004; 162: 377-89. DOI: https://doi.org/10.1667/RR3232
35) Preston DL, Pierce DA, Shimizu Y, Ron E, Mabuchi K. Dose response and temporal patterns of radiation-associated solid cancer risks. Health Phys 2003; 85(1): 43-46. DOI: https://doi.org/10.1097/00004032-200307000-00010
36) Preston DL, Ron E, Tokuoka S, Funamoto S, Nishi N, Soda M, Mabuchi K, Kodama, K. Solid cancer incidence in atomic bomb survivors: 1958-98. RERF Update. 2007; 18: 9-13. DOI: https://doi.org/10.1667/RR0763.1
37) Preston DL, Shimizu Y, Pierce DA, Suyama A, Mabuchi K. Studies of mortality of atomic bomb survivors. Report 13: Solid cancer and noncancer disease mortality: 1950-1997. Radiat Res 2003; 160: 381-407. 38) Richardson, D. et al. lonizing radiation and leukemia mortality among Japanese Atomic bomb survivors, 1950-2000. Radiat Res 2009; 172, 368-82. DOI: https://doi.org/10.1667/RR3049
39) Shuryak I, Hahnfeldt P, Hlatky L, Sachs RK, Brenner DJ. A new view of radiation-induced cancer: integrating short- and long-term processes. Part Il: second cancer risk estimation. Radiat Environ Biophys 2009 Aug; 48(3): 275-86. DOI: https://doi.org/10.1007/s00411-009-0231-2
40) Thomas CC Pub. The Physics of Radiology. Third Edition, 1978, ISBN 10: 0398030073 ISBN 13: 9780398030070 41) Travis LB, Hill DA, Dores GM, et al. Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease. JAMA 2003; 290: 465-75.
42) United Nations Scientific Committee on the Effects of Atomic Radiation. Sources, effects and risks of ionizing radiation. UNSCEAR 2012 Report. United Nations New York, 2015.
43) United Nations Scientific Committee on the Effects of Atomic Radiation. Biological mechanisms of radiation actions at low doses. United Nations. New York, 2012.
44) Yingjie Z, Liang J, Hui L, Hui C, Yansong L. Risk of second primary breast cancer after radioactive iodine treatment in thyroid cancer: a systematic review and meta-analysis. Nuclear Medicine Communications 2016; 37: 110-115. DOI: https://doi.org/10.1097/MNM.0000000000000419
45) Vrijheida M, Cardis E, Ashmorec P, Auvinend A, Gilberte E, Habibf RR, Malkerg H, Muirheadh CR, Richardsoni DB, Rogelj A, Schubauer-Berigank M, Tardya H, Telle-Lambertonj M. lonizing Radiation and Risk of Chronic Lymphocytic Leukemia in the 15-Country Study of Nuclear Industry Workers. Radiat Res 2008 November; 170(5): 661-665. doi: 10.1667/RR1443.1. DOI: https://doi.org/10.1667/RR1443.1
46) Weiss HA, Darby SC, Doll R. Cancer mortality following X-ray treatment for ankylosing spondylitis. Int J Cancer, 59: 327-338. 1994. doi: 10.1002/ijc.2910590307 PMID: 7927937 DOI: https://doi.org/10.1002/ijc.2910590307
How to Cite
[The stochastic effects of ionising radiation]: Gli effetti stocastici delle radiazioni ionizzanti. (2017). Giornale Italiano Di Medicina Del Lavoro Ed Ergonomia, 39(2), 116-123. https://doi.org/10.4081/gimle.615
Copyright (c) 2017 The Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.